Bioprocess Sciences and Technology of Viral Vaccines

疫苗接种是已知的最成功和最具成本效益的卫生干预措施之一。随着免疫战略的发展，生产疫苗的方法也在不断发展，并创造了新的疫苗机会。现代疫苗开发目前正在利用重组DNA技术和细胞培养平台的进展来生产更安全、更有效和更具成本效益的疫苗，包括病毒载体和病毒样颗粒疫苗。CRC病毒疫苗生物工艺科学和技术的研究计划旨在解决细胞培养生物加工中的关键挑战-生产病毒疫苗，加快先进生产技术的发展，培养急需的人才。

Vaccination is one of the most successful and cost-effective health interventions known. As immunization strategies have advanced, the methods to produce vaccines have evolved and new vaccine opportunities have been created. Modern vaccine development is currently exploiting progress in recombinant DNA technology and cell culture platforms to produce safer, more efficacious and cost-effective vaccines, including viral vectors and viral-like particles vaccines.The research program of the CRC Bioprocess Sciences and Technology of Viral Vaccines has been designed to address critical challenges in bioprocessing of cell culture-produced viral vaccines to accelerate the development of advanced manufacturing technologies and train highly needed qualified personnel.